Correlation between preeclampsia and prevalence of polymorphism of angiotensinogen, methyleneteterahydrofolate reductase and factor V, prothrombin genes among Japanese women

Acta Medica Nagasakiensia

Volumn 53, Issue 2, 2008, Pages 37-41

  Yoshida, Atsushi ^a   Miura, Kiyonori ^a   Nakayama, Daisuke ^a   Masuzaki, Hideaki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Angiotensinogen; Factor V; Methlenetetrahydrofolate; Polymorphism; Preeclampsia; Prothrombin

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANGIOTENSINOGEN; BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ADULT; ARTICLE; BLOOD ANALYSIS; DNA EXTRACTION; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; PATHOGENICITY; PREECLAMPSIA; PREGNANT WOMAN;

EID: 57349091735     PISSN: 00016055     EISSN: 00016055     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Roberts JM, Cooper DW (2001) Pathogenesis and genetics of pre-eclampsia. Lancet 357: 53-56, 2001
2. Chesley L. Annito J. Cosgrove R. The familial factor in toxemia of pregnancy. Obstet Gynecol 32: 303-311, 1968
3. Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 93: 898-908, 1986
4. Kamitani A. Rakugi H, Higaki J et al. Association analysis of polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 8: 521-524, 1994
5. Morita H, Taguchi J, Kurihara H et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95: 2032-2036, 1997
6. Zoller B, Svensson P, He X, Dahlback B. Identification of the same factor 5 gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clinical Invest 94: 2521-2524, 1994
7. Poort S, Michiels J, Reitsma P, Bertina R. Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder. Thromb Haemost 72: 819-824, 1994
8. Ward K, Hata A, Jeunemaitre X, Helin C et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 4: 59-61, 1993
9. Hata A, Namikawa C, Sasaki M, Sato K et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 93: 1285-1287, 1994
10. Souda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 34: 525-526, 1997
11. Rees D, Cox M, Clegg J. World distribution of factor V Leiden. Lancet 346: 1133-1134, 1995
12. Roberts J, Redman C. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341: 1447-1451, 1993
13. Klipatrick D, Liston W, Gibson F, Livinstone J. Association between susceptibility to pre-eclampsia within families and HLA DR4. Lancet 2: 1063-1065, 1989
14. Liston W, Klipatrick D. Is genetic susceptibility to pre-eclampsia conferred by homozygosity for the same single recessive gene in mother and fetus? Br J Obstet Gynecol 98: 1079-1086, 1991
15. Jeunemaitre X, Soubrier F, Kotelevtsev Y et al. Morecular basis of human hypertension: role of angiotensinogen. Cel 171: 7-20, 1992
16. Kobashi G, Hata A, Fujimoto S. Association of pregnancy-induced hypertension with a molecular variant of angiotensinogen gene. Nippon Sanka Fujinka Zassi 47: 497-498, 1995
17. Morgan L. Preeclampsia and the angiotensinogen gene. Br J Obstet Gynecol 70: 649-657, 1995
18. Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: -26An independent risk factor for vascular disease. N England J Med 324: 1149-1155, 1991
19. Kupferminc MJ, Baram A, Jaffa AJ, Wolman I, Shenhav M, Leesing JB. Increased frequency of genetic thrombophilia in women with pre-eclampsia. N Engl J Med 340: 9-13, 1999
20. Frosst P, Blom HJ, Millos R et al. A candidate risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 10: 111-113, 1995
21. Ballegeer V, Spitz P, De Baene L, Van Assche A, Hidajat M, Criel A. Platelet activation and vascular damage in gestational hypertension. Am J Obstet Gynecol 166: 629-633, 1992
22. Haller H, Hempel A, Homuth V et al. Endometrial-cell permeability and protein kinese C in pre-eclampsia. Lancet 351: 954-959, 1998
23. Kobashi G, Yamada H, Asano T et al. Absence of association between a common mutation in the methyleneteterahydrofolate reductase gene and preeclampsia in Japanese women. Am J Med Genet 93(2): 122-125, 2000
24. Stonek F, Hafner E, Philipp K et al. Methylenetetrahydrofolate reductase C677Y polymorphism and pregnancy complications. Obstet Gynecol 110: 363-368, 2007
25. Jarvenpaa J, Pakkila M, Savolainen E.-R, Perheentupa A, Jarvela I, Ryynanen M. Evaluation of Factor V Leiden, Prothrombin and Methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy induced complications in northern Finland. Gynecol Obstet Invest 62: 28-32, 2006
26. Prasmusinto D, Skrablin S, Fimmers R, van der Ven K. Ethnic differences in the association of factor V Leiden mutation and the C677T methylenetetrahydrofolate reductase gene polymorphism with preeclampsia. Eur J Obstet Gynecol Reprod Biol 112: 162-169, 2004
27. Zahed L, Rayes R, Mahfouz R et al. Prevalence of factor V Leiden, prothorombin and methylene tetrahydrofolate reductase mutations in women with adverse outcomes in Levanon. Am J Obstet Gynecol 195: 1114-1118, 2006
28. Dizon-Townson D, Nelson L, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 175: 902-905, 1996
29. Suzan R Kahn. Severe preeclampsia associated with coinheritance of factor V Leiden mutation and protein S deficiency. Obstet Gynecol 91: 812-814, 1998
30. Grandone E, Margaglione M, Colarizzo D et al. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 77: 1052-1054, 1997